YNG-50300-72385
4 vaccinations
7 coded responses
13 check-ins
6 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 801 / CO
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-26
Dose 1 — Moderna
-
2021-02-23
Dose 2 — Moderna
-
2021-03-10
Registered in v-safe
-
2021-03-10
Survey response — day 14, dose 2MedDRA: Ageusia, Anosmia, Hypoaesthesia oral, SARS-CoV-2 test, SARS-CoV-2 test negative — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Beginning about March 1 or March 2, noticed that I began losing some of my sense of taste and smell. Received a COVID-19 test on March 6 with negative test results received on March 7. Taste and smell are still impaired - my tongue seems numb. · Healthcare visit (other): COVID-19 testMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-10
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professionalno matching call case
- 2021-03-17
- 2021-03-23
- 2021-03-30
-
2021-04-08
Survey response — day 42, dose 2MedDRA: Ageusia, Anosmia, Glossitis — Feeling: FairFree text: Decreased sense of smell and taste. Inflamed tongue.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-27
-
2021-08-24
Survey response — 6 months, dose 2MedDRA: Parosmia, Taste disorder — Feeling: GoodFree text: Altered sense of taste and smell.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-07
Dose 3 — Moderna
- 2021-10-25
-
2021-12-07
Survey response — 3 months, dose 3MedDRA: Nasopharyngitis — Feeling: GoodFree text: Suspected I might have had a breakthrough case, got tested negative, turned out to be a cold.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-10
Dose 4 — Moderna
-
2022-03-11
Survey response — 6 months, dose 3MedDRA: Headache — Feeling: FairFree text: Headache over the past weekMedDRA releases: 2024-11 · check-in free text available
-
2022-05-12
Survey response — 3 months, dose 4MedDRA: Hypogeusia, Hyposmia — Feeling: FairFree text: Received fourth moderna shot in early February. Since then, have had reduced sense of taste and smell.MedDRA releases: 2024-11 · check-in free text available
- 2022-08-11
-
2023-02-10
Survey response — 12 months, dose 4MedDRA: Sinusitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-02-10
Report sent to call center — 12 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-02-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-26 | Moderna | |
| 2 | 2021-02-23 | Moderna | |
| 3 | 2021-09-07 | Moderna | No |
| 4 | 2022-02-10 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-02-10 | Unsuccessful |
1 report(s) with no call case — see the timeline.
Free text
Release 5 — day 14, dose 2
Symptoms: Beginning about March 1 or March 2, noticed that I began losing some of my sense of taste and smell. Received a COVID-19 test on March 6 with negative test results received on March 7. Taste and smell are still impaired - my tongue seems numb.
Healthcare visit (other): COVID-19 test
Release 7 — day 42, dose 2
Symptoms: Decreased sense of smell and taste. Inflamed tongue.
Release 9 — 6 months, dose 2
Symptoms: Altered sense of taste and smell.
Release 10 — 3 months, dose 3
Symptoms: Suspected I might have had a breakthrough case, got tested negative, turned out to be a cold.
Release 11 — 6 months, dose 3
Symptoms: Headache over the past week
Release 11 — 3 months, dose 4
Symptoms: Received fourth moderna shot in early February. Since then, have had reduced sense of taste and smell.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | SARS-CoV-2 test | ✓ | ✓ | ✓ |
| SD | Ageusia | ✓ | ✓ | ✓ |
| SD | Anosmia | ✓ | ✓ | ✓ |
| SD | Glossitis | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypoaesthesia oral | ✓ | ✓ | ✓ |
| SD | Hypogeusia | · | · | ✓ |
| SD | Hyposmia | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Parosmia | ✓ | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Taste disorder | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release